Healthy Skepticism Library item: 8394

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Pharmaceutical R&D must be encouraged and supported, CMA tells the Eastman Commission
Canadian Medical Association Journal 1984 Nov 1; 131:1095-1097

Abstract:

The Canadian Medical Association’s report favoring innovation by pharmaceutical manufacturers in Canada and patients’ rights to receive specific, quality prescription products is discussed. Problems resulting from the 1969 amendment to the patent act and legislation permitting or mandating drug product selection or substitution are discussed. Recommendations include: the provision of information on preparations subject to product selection or substitution to health care practitioners on demand; guarantees by the health protection branch of the government of the quality, safety and efficacy of all prescription drugs; and encouragement and support of research, development, and the introduction of new drugs by a viable and competitive pharmaceutical industry.